QIM
PACB icon

Quantitative Investment Management’s Pacific Biosciences PACB Stock Holding History

Quantitative Investment Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,417
Closed -$138K – 293
2023
Q2 		$138K Sell
10,417
-4,675
-31% -$56.8K 0.01% 263
2023
Q1 		$174K Buy
+15,092
New +$150K 0.04% 211
2016
Q4 		– Sell
-34,600
Closed -$310K – 913
2016
Q3 		$310K Buy
+34,600
New +$289K 0.01% 593

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.39B AUM 10.34% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Quantitative Investment Management's PACB Position: Q3 2023 in Review

Quantitative Investment Management sold out of Pacific Biosciences (PACB) in Q3 2023, closing a stake of 10,417 shares — an estimated $138K sold.

Quantitative Investment Management first reported a position in PACB in Q3 2016 and held it in 3 quarters. The position peaked at $310K in Q3 2016. 273 funds tracked by Wall St. Rank hold PACB as of Q3 2023.

  • Quantitative Investment Management reported no remaining Pacific Biosciences position as of Q3 2023 after selling out during the quarter.
  • Quantitative Investment Management sold 10,417 Pacific Biosciences shares in Q3 2023, an estimated $138K.
  • Quantitative Investment Management first reported a position in Pacific Biosciences in Q3 2016 and held it in 3 quarters.
  • Quantitative Investment Management's Pacific Biosciences position peaked at $310K in Q3 2016.
  • 273 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2023.

Based on Quantitative Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.